Nanobiotix Announces Issue of European Patent Protecting Its nanoXray(TM) Anticancer Platform
PARIS--(BUSINESS WIRE)--Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the European Patent Office (EPO) has issued Patent No. 1744789 to the Company, related to its “novel activable particles that can be used in the health sector.”